Risk-Reducing Gynecological Surgery in Lynch Syndrome: Results of an International Survey from the Prospective Lynch Syndrome Database.
Autorzy:
Dominguez-Valentin M; Department of Tumor Biology, Institute of Cancer Research, The Norwegian Radium Hospital, Part of Oslo University Hospital, 0379 Oslo, Norway. Seppälä TT; Department of Abdominal Surgery, Helsinki University Central Hospital, 00029 Helsinki, Finland.; Faculty of Medicine, University of Helsinki, 00014 Helsinki, Finland. Engel C; Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, 04107 Leipzig, Germany. Aretz S; Institute of Human Genetics, University of Bonn, 53127 Bonn, Germany.; Center for Hereditary Tumor Syndromes, University Hospital Bonn, 53127 Bonn, Germany. Macrae F; Colorectal Medicine and Genetics, The Royal Melbourne Hospital, 3052 Melbourne, Australia.; Department of Medicine, University of Melbourne, 3052 Melbourne, Australia. Winship I; Colorectal Medicine and Genetics, The Royal Melbourne Hospital, 3052 Melbourne, Australia.; Department of Medicine, University of Melbourne, 3052 Melbourne, Australia. Capella G; Hereditary Cancer Program, Catalan Institute of Oncology, Insititut d'Investigació Biomèdica de Bellvitge (IDIBELL), ONCOBELL Program, L'Hospitalet de Llobregat, 08908 Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), 28029 Madrid, Spain. Thomas H; Department of Surgery and Cancer, St Mark's Hospital, Imperial College London, London HA1 3UJ, UK. Hovig E; Department of Tumor Biology, Institute of Cancer Research, The Norwegian Radium Hospital, Part of Oslo University Hospital, 0379 Oslo, Norway.; Center for Bioinformatics, Department of Informatics, University of Oslo, 0316 Oslo, Norway. Nielsen M; Leids Universitair Medisch Centrum, Department of Clinical Genetics, 2300RC Leiden, The Netherlands. Sijmons RH; Department of Genetics, University of Groningen, University Medical Center Groningen, 9713GZ Groningen, The Netherlands. Bertario L; Scientific Consultant of the Division of Prevention and Genetic Oncology, European Institute of Oncology, Fondazione IRCCS Isrtituto nazionale dei Tumori, 20141 Milan, Italy. Bonanni B; Division of Prevention and Genetic Oncology, European Institute of Oncology, 20141 Milan, Italy. Tibiletti MG; Ospedale di Circolo ASST Settelaghi, Centro di Ricerca Tumori Eredo-Familiari, Università dell'Insubria, 21100 Varese, Italy. Cavestro GM; Gastroenterology and Gastrointestinal Endoscopy Unit, Vita-Salute San Raffaele University, San Raffaele Scientific Institute, 20132 Milan, Italy. Mints M; Karolinska Institutet, 171 76 Stockholm, Sweden. Gluck N; Department of Gastroenterology, Tel-Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel-Aviv University, 64239 Tel Aviv, Israel. Katz L; Department of Gastroenterology and Hepatology, Hadassah Medical Center, 91120 Jerusalem, Israel. Heinimann K; Medical Genetics, Institute for Medical Genetics and Pathology, University Hospital Basel, 4031 Basel, Switzerland. Vaccaro CA; Hereditary Cancer Program (PROCANHE) Hospital Italiano de Buenos Aires, C1199ABB Ciudad Autónoma de Buenos Aires, Argentina. Green K; University of Manchester & Manchester University NHS Foundation Trust, Manchester M13 9WL, UK. Lalloo F; University of Manchester & Manchester University NHS Foundation Trust, Manchester M13 9WL, UK. Hill J; Department of Surgery, Manchester University NHS Foundation Trust and University of Manchester, Manchester M13 9WL, UK. Schmiegel W; Department of Medicine, Knappschaftskrankenhaus, Ruhr-University Bochum, 44801 Bochum, Germany. Vangala D; Department of Medicine, Knappschaftskrankenhaus, Ruhr-University Bochum, 44892 Bochum, Germany. Perne C; Institute of Human Genetics, University of Bonn, 53127 Bonn, Germany.; Center for Hereditary Tumor Syndromes, University Hospital Bonn, 53127 Bonn, Germany. Strauß HG; Department of Gynecology, University Clinics, Martin-Luther University, D-06097 Halle (Saale), Germany. Tecklenburg J; Institute of Human Genetics, Hannover Medical School, 30625 Hannover, Germany. Holinski-Feder E; Medizinische Klinik und Poliklinik IV, Campus Innenstadt, Klinikum der Universität München, 80336 Munich, Germany.; MGZ-Medical Genetics Center, 80335 Munich, Germany. Steinke-Lange V; Medizinische Klinik und Poliklinik IV, Campus Innenstadt, Klinikum der Universität München, 80336 Munich, Germany.; MGZ-Medical Genetics Center, 80335 Munich, Germany. Mecklin JP; Faculty of Sport and Health Sciences, University of Jyväskylä, 40014 Jyväskylä, Finland.; Department of Surgery, Central Finland Health Care District, 40620 Jyväskylä, Finland. Plazzer JP; Colorectal Medicine and Genetics, The Royal Melbourne Hospital, 3052 Melbourne, Australia. Pineda M; Hereditary Cancer Program, Catalan Institute of Oncology, Insititut d'Investigació Biomèdica de Bellvitge (IDIBELL), ONCOBELL Program, L'Hospitalet de Llobregat, 08908 Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), 28029 Madrid, Spain. Navarro M; Hereditary Cancer Program, Catalan Institute of Oncology, Insititut d'Investigació Biomèdica de Bellvitge (IDIBELL), ONCOBELL Program, L'Hospitalet de Llobregat, 08908 Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), 28029 Madrid, Spain. VidalJB; Hereditary Cancer Program, Catalan Institute of Oncology, Insititut d'Investigació Biomèdica de Bellvitge (IDIBELL), ONCOBELL Program, L'Hospitalet de Llobregat, 08908 Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), 28029 Madrid, Spain. Kariv R; Department of Gastroenterology, Tel-Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel-Aviv University, 64239 Tel Aviv, Israel. Rosner G; Department of Gastroenterology, Tel-Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel-Aviv University, 64239 Tel Aviv, Israel. Piñero TA; Hereditary Cancer Program (PROCANHE) Hospital Italiano de Buenos Aires, C1199ABB Ciudad Autónoma de Buenos Aires, Argentina. Gonzalez ML; Hereditary Cancer Program (PROCANHE) Hospital Italiano de Buenos Aires, C1199ABB Ciudad Autónoma de Buenos Aires, Argentina. Kalfayan P; Hereditary Cancer Program (PROCANHE) Hospital Italiano de Buenos Aires, C1199ABB Ciudad Autónoma de Buenos Aires, Argentina. Sampson JR; Institute of Medical Genetics, Division of Cancer and Genetics, Cardiff University School of Medicine, Cardiff CF14 4XN, UK. Ryan NAJ; University of Manchester & Manchester University NHS Foundation Trust, Manchester M13 9WL, UK. Evans DG; University of Manchester & Manchester University NHS Foundation Trust, Manchester M13 9WL, UK. Møller P; Department of Tumor Biology, Institute of Cancer Research, The Norwegian Radium Hospital, Part of Oslo University Hospital, 0379 Oslo, Norway. Crosbie EJ; University of Manchester & Manchester University NHS Foundation Trust, Manchester M13 9WL, UK.
Survival by colon cancer stage and screening interval in Lynch syndrome: a prospective Lynch syndrome database report.
Autorzy:
Dominguez-Valentin M; 1Department of Tumor Biology, Institute of Cancer Research, Oslo University Hospital, Oslo, Norway. Seppälä TT; 2Department of Gastrointestinal Surgery, Helsinki University Central Hospital, Helsinki, Finland.; 3Clinicum, University of Helsinki, Helsinki, Finland. Sampson JR; 4Division of Cancer and Genetics, Institute of Medical Genetics, Cardiff University School of Medicine, Cardiff, UK. Macrae F; 5The Royal Melbourne Hospital, Melbourne, Australia.; 6University of Melbourne, Melbourne, Australia. Winship I; 5The Royal Melbourne Hospital, Melbourne, Australia.; 6University of Melbourne, Melbourne, Australia. Evans DG; 7University of Manchester & Manchester University Hospitals Foundation Trust, Manchester, UK. Scott RJ; University of Newcastle and the Hunter Medical Research Institute, Callaghan, Australia. Burn J; 9University of Newcastle, Newcastle upon Tyne, UK. Möslein G; 10University Witten-Herdecke, Wuppertal, Germany. Bernstein I; 11Department of Surgical Gastroenterology, Aalborg University Hospital, Aalborg, Denmark. Pylvänäinen K; 12Central Finland Central Hospital, Education and Research, Jyväskylä, Finland. Renkonen-Sinisalo L; 2Department of Gastrointestinal Surgery, Helsinki University Central Hospital, Helsinki, Finland.; 13Research Programs Unit, Genome-Scale Biology, University of Helsinki, Helsinki, Finland. Lepistö A; 2Department of Gastrointestinal Surgery, Helsinki University Central Hospital, Helsinki, Finland.; 13Research Programs Unit, Genome-Scale Biology, University of Helsinki, Helsinki, Finland. Lindblom A; 14Karolinska Institutet, Stockholm, Sweden. Plazzer JP; 5The Royal Melbourne Hospital, Melbourne, Australia. Tjandra D; 6University of Melbourne, Melbourne, Australia. Thomas H; 15St Mark's Hospital, Department of Surgery and Cancer, Imperial College London, London, UK. Green K; 7University of Manchester & Manchester University Hospitals Foundation Trust, Manchester, UK. Lalloo F; 7University of Manchester & Manchester University Hospitals Foundation Trust, Manchester, UK. Crosbie EJ; 16University of Manchester and St Mary's Hospital, Manchester, UK. Hill J; 7University of Manchester & Manchester University Hospitals Foundation Trust, Manchester, UK. Capella G; 17Hereditary Cancer Program, Catalan Institute of Oncology, Insititut d'Investigació Biomèdica de Bellvitge (IDIBELL), ONCOBELL Program, L'Hospitalet de Llobregat, Barcelona, Spain.; 18Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain. Pineda M; 17Hereditary Cancer Program, Catalan Institute of Oncology, Insititut d'Investigació Biomèdica de Bellvitge (IDIBELL), ONCOBELL Program, L'Hospitalet de Llobregat, Barcelona, Spain.; 18Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain. Navarro M; 17Hereditary Cancer Program, Catalan Institute of Oncology, Insititut d'Investigació Biomèdica de Bellvitge (IDIBELL), ONCOBELL Program, L'Hospitalet de Llobregat, Barcelona, Spain.; 18Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain. VidalJB; 17Hereditary Cancer Program, Catalan Institute of Oncology, Insititut d'Investigació Biomèdica de Bellvitge (IDIBELL), ONCOBELL Program, L'Hospitalet de Llobregat, Barcelona, Spain.; 18Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain. Rønlund K; 19Department of Clinical Genetics, Vejle Hospital, Vejle, Denmark. Nielsen RT; 20Department of Surgery, Regional Hospital West Jutland, Egtved, Denmark. Yilmaz M; 21Department of Oncology, Aalborg University Hospital, Aalborg, Denmark. Elvang LL; 22Department of Pathology, Herlev Gentofte University Hospital, Herlev, Denmark. Katz L; 23High Risk and GI Cancer prevention Clinic, Gatro-Oncology Unit, The Department of Gastroenterology, Sheba Medical Center, Ramat Gan, Israel. Nielsen M; 24Leids Universitair Medisch Centrum, Leiden, Netherlands. Ten Broeke SW; 24Leids Universitair Medisch Centrum, Leiden, Netherlands. Nakken S; 1Department of Tumor Biology, Institute of Cancer Research, Oslo University Hospital, Oslo, Norway. Hovig E; 1Department of Tumor Biology, Institute of Cancer Research, Oslo University Hospital, Oslo, Norway.; 25Center for Bioinformatics, Department of Informatics, University of Oslo, Oslo, Norway. Sunde L; 26Department of Clinical Genetics, Aarhus University Hospital, Aarhus, Denmark. Kloor M; 27Department of Applied Tumor Biology, Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.; 28Cooperation Unit Applied Tumor Biology, German Cancer Research Center (DKFZ), Heidelberg, Germany. Knebel Doeberitz MV; 27Department of Applied Tumor Biology, Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.; 28Cooperation Unit Applied Tumor Biology, German Cancer Research Center (DKFZ), Heidelberg, Germany. Ahadova A; 27Department of Applied Tumor Biology, Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.; 28Cooperation Unit Applied Tumor Biology, German Cancer Research Center (DKFZ), Heidelberg, Germany. Lindor N; 29Department of Health Sciences Research, Mayo Clinic, Scottsdale, AZ USA. Steinke-Lange V; 30Medizinische Klinik und Poliklinik IV, Campus Innenstadt, Klinikum der Universität München, Munich, Germany.; 31MGZ- Medical Genetics Center, Munich, Germany. Holinski-Feder E; 30Medizinische Klinik und Poliklinik IV, Campus Innenstadt, Klinikum der Universität München, Munich, Germany.; 31MGZ- Medical Genetics Center, Munich, Germany. Mecklin JP; 32Department of Surgery, Central Finland Central Hospital, Jyväskylä, Finland.; 33Faculty of Sport and Health Sciences, University of Jyväskylä, Jyväskylä, Finland. Møller P; 1Department of Tumor Biology, Institute of Cancer Research, Oslo University Hospital, Oslo, Norway.
Pokaż więcej
Źródło:
Hereditary cancer in clinical practice [Hered Cancer Clin Pract] 2019 Oct 14; Vol. 17, pp. 28. Date of Electronic Publication: 2019 Oct 14 (Print Publication: 2019).
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies
